Goals and format
Because of the progressively
larger emergence of resistance to existing antimicrobials, new chemical
entities will be needed in the very near future. In order for those
to become useful drugs, toxicological issues must be met preferably from
an early stage of discovery and development. The symposium reviewed
some of the most recent approaches in toxicodynamics and toxicokinetics
which may allow for a safer and faster development of new antibiotics.
The symposium examined how these concepts can be applied to existing drugs
in order to provide patients with safer treatments.
![]() |
R. Brasseur (Gembloux Agricultural University, Department of Numeric Molecular Biophysics, Gembloux, Belgium) P.M. Tulkens (Catholic University of Louvain, Cellular and Molecular Pharmacology, Brussels, Belgium) D. Nicolau (Hartford Hospital, Department of Pharmacy Research, Hartford, CT) |
The symposium was eligible
for Continuing education / Accreditation physicians and pharmacists).